Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VEAC

Vantage Energy Acquisition (VEAC) Stock Price, News & Analysis

Vantage Energy Acquisition logo

About Vantage Energy Acquisition Stock (NASDAQ:VEAC)

Advanced Chart

Key Stats

Today's Range
$10.21
$10.23
50-Day Range
$10.21
$10.21
52-Week Range
$9.76
$10.28
Volume
5,922 shs
Average Volume
211,644 shs
Market Capitalization
$704.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VEAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vantage Energy Acquisition and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VEAC Stock News Headlines

Project Energy Reimagined Acquisition Corp.
New Biotech Backed by Proven Incubator Now Open to Public
A successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal comes from the same team that helped guide ANOTHER rare disease biotech to a $680M acquisition. Now, they've lined up a new candidate: a drug with orphan status and fast-track designation, entering Phase 2 trials.tc pixel
See More Headlines

VEAC Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Vantage Energy Acquisition investors own include Allena Pharmaceuticals (ALNA), AstroNova (ALOT), Senseonics (SENS), Surgery Partners (SGRY), Ampliphi Biosciences (APHB), Conduent (CNDT) and Corbus Pharmaceuticals (CRBP).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
Holding & Other Investment Offices
Sub-Industry
N/A
Current Symbol
NASDAQ:VEAC
CIK
1698209
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$4.05 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
81.14%
Return on Assets
0.73%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.01
Quick Ratio
0.01

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.06 per share
Price / Cash Flow
174.03
Book Value
$0.07 per share
Price / Book
145.86

Miscellaneous

Outstanding Shares
69,000,000
Free Float
N/A
Market Cap
$704.49 million
Optionable
Not Optionable
Beta
0.02
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:VEAC) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners